Reported Feb 16, 2022 · Ongoing
THERAKOS CELLEX Photopheresis Procedural Kit, CLXUSA
Mallinckrodt Pharmaceuticals Ireland Ltd.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Mallinckrodt Pharmaceuticals Ireland Ltd · College Business & Technology Park · Dublin 15, N/A · N/A
Is this the product you have?
- THERAKOS CELLEX Photopheresis Procedural Kit, CLXUSA
- Lot codes and dates
- Dunnage case consists of a random unknown lot, which may have been shipped in place of Kit lot K341
- Amount recalled
- 3
Where it was sold
Why it was recalled
This recall was initiated to recover a Dunnage Case, which is a case of three (3) CLXUSA kits. This Dunnage Case was shipped on 02-Dec-2021. Dunnage is used during the sterilization process and is not intended for customer use.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Mallinckrodt Pharmaceuticals Ireland Ltd. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.